Talphera, Inc. (TLPH) — 10-Q Filings
All 10-Q filings from Talphera, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Talphera's Q3 Loss Widens Amid Going Concern Doubts, Cash Dwindles
— Nov 12, 2025 Risk: high
TALPHERA, INC. (TLPH) reported a net loss of $4.436 million for the three months ended September 30, 2025, an increase from a net loss of $3.353 million in the -
Talphera Narrows Losses Amidst Cash Burn, Going Concern Doubts Persist
— Aug 14, 2025 Risk: high
TALPHERA, INC. (TLPH) reported a net loss of $3.489 million for the three months ended June 30, 2025, a slight improvement from the $3.827 million net loss in t -
Talphera, Inc. Reports Q1 2025 Results, Private Placement
— May 14, 2025 Risk: medium
Talphera, Inc. (formerly AcelRx Pharmaceuticals Inc.) filed a 10-Q for the period ending March 31, 2025. The company reported on its financial activities, inclu -
Talphera, Inc. Files Q3 2024 10-Q
— Nov 13, 2024 Risk: medium
Talphera, Inc. (formerly AcelRx Pharmaceuticals Inc.) filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and oper -
Talphera, Inc. Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Talphera, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as AcelRx Pharmaceuticals Inc., reported on its financial status -
Talphera, Inc. Files 10-Q for Q1 2024
— May 14, 2024 Risk: low
TALPHERA, INC. (TLPH) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Talphera, Inc. (formerly AcelRx Pharmaceuticals Inc.) filed its Q1 2024 10-Q
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX